| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calmodulin binding | MYH11 ARPP21 MYLK MYO1A IQGAP2 MYO5A MYO7A SPTBN1 MYO5C IQGAP1 EEF2K TRPV1 MKNK1 EPB41 | 5.55e-08 | 230 | 193 | 14 | GO:0005516 |
| GeneOntologyMolecularFunction | actin binding | KIF18A MYH11 MYLK MYO1A IQGAP2 MYO5A MYO7A SPTBN1 MYO5C IQGAP1 MYO3B SYNE2 CGN PPP1R9A MYO18A WHAMM GSN STK38L EPB41 | 2.18e-07 | 479 | 193 | 19 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF18A MYH11 MYLK MYO1A IQGAP2 MYO5A MYO7A DISC1 SPTBN1 APC2 PACSIN3 CCDC88B MAPK8IP3 MYO5C IQGAP1 FARP2 NDC80 MYO3B SYNE2 CGN MTCL1 JAKMIP1 PPP1R9A MYO18A WHAMM GSN STK38L EPB41 NIN | 8.19e-07 | 1099 | 193 | 29 | GO:0008092 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.61e-06 | 38 | 193 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.21e-06 | 118 | 193 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH11 MYO1A IQGAP2 MYO5A MYO7A SPTBN1 MYO5C IQGAP1 PPP1R9A MYO18A GSN | 1.36e-05 | 227 | 193 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 1.25e-04 | 27 | 193 | 4 | GO:0023026 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | IQGAP2 RGPD1 PGAM5 IQGAP1 FARP2 HERC2 MCF2L DNMBP PREX1 RGPD5 RGPD8 ARHGEF18 OCRL RABEP1 GPSM3 | 1.28e-04 | 507 | 193 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | IQGAP2 RGPD1 PGAM5 IQGAP1 FARP2 HERC2 MCF2L DNMBP PREX1 RGPD5 RGPD8 ARHGEF18 OCRL RABEP1 GPSM3 | 1.28e-04 | 507 | 193 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 1.39e-04 | 11 | 193 | 3 | GO:0032395 | |
| GeneOntologyMolecularFunction | kinase activity | HK2 MYLK PDK1 CLK4 BMPR1A MYO3B PKLR EEF2K DGKZ LCK MKNK1 MST1R FRK PALS1 PRKG2 PALS2 STK38L HCK | 4.59e-04 | 764 | 193 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | MHC protein complex binding | 6.48e-04 | 41 | 193 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | HK2 MYLK PDK1 CLK4 BMPR1A MYO3B PKLR EEF2K POLG DGKZ LCK MKNK1 MST1R FRK PALS1 NANS PRKG2 PALS2 STK38L HCK | 7.83e-04 | 938 | 193 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | GTPase binding | IQGAP2 MYO5A SPTBN1 RGPD1 IQGAP1 RGPD8 PPP1R9A DVL3 WHAMM OCRL STRIP1 | 7.88e-04 | 360 | 193 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A MYH11 ABCF3 MYO1A MYO5A MYO7A DHX38 MCM7 MYO5C MYO3B ABCD2 DNAH9 ABCC1 MYO18A TP53 | 9.57e-04 | 614 | 193 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | histone H2A ubiquitin ligase activity | 1.36e-03 | 6 | 193 | 2 | GO:0141053 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | HECW1 RGPD1 FBXW8 KLHL21 FBXO7 HERC2 UBE2E3 UBR2 RC3H2 RGPD8 WWP1 RNF2 PDZRN3 | 1.48e-03 | 512 | 193 | 13 | GO:0019787 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | HK2 MYLK PDK1 CLK4 BMPR1A MYO3B PKLR EEF2K DGKZ LCK MKNK1 MST1R FRK PRKG2 STK38L HCK | 1.49e-03 | 709 | 193 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.62e-03 | 279 | 193 | 9 | GO:0005096 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KIF18A MYH11 MYO1A IQGAP2 MYO5A MYO7A USP9X SPTBN1 APC2 CCDC88B GFAP MYO5C IQGAP1 RHPN1 EEF2K PREX1 ADAMTS3 ADAMTS2 PPP1R9A WHAMM ARHGEF18 GSN CST2 HCK NIN | 1.94e-06 | 957 | 187 | 25 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH11 MYO1A IQGAP2 MYO5A MYO7A SPTBN1 MYO5C IQGAP1 FARP2 RHPN1 MYO3B SYNE2 EEF2K PREX1 PPP1R9A MYO18A DVL3 WHAMM ARHGEF18 GSN STRIP1 PARD3 HCK EPB41 | 2.80e-06 | 912 | 187 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH11 MYO1A IQGAP2 MYO5A MYO7A SPTBN1 MYO5C IQGAP1 FARP2 RHPN1 MYO3B EEF2K PREX1 PPP1R9A MYO18A DVL3 WHAMM ARHGEF18 GSN STRIP1 HCK EPB41 | 3.97e-06 | 803 | 187 | 22 | GO:0030036 |
| GeneOntologyCellularComponent | myosin complex | 6.24e-08 | 59 | 191 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH11 MYLK ACACA MYO1A IQGAP2 MYO5A MYO7A SPTBN1 APC2 TMEM63B MYO5C IQGAP1 MYO3B CGN PPP1R9A MYO18A GSN MST1R STK38L HCK EPB41 | 7.79e-08 | 576 | 191 | 21 | GO:0015629 |
| GeneOntologyCellularComponent | cell leading edge | KIF18A MYLK MYO1A IQGAP2 MYO5A SPTBN1 APC2 MAPK8IP3 IQGAP1 SYNE2 MCF2L TRPV1 ATN1 PPP1R9A DGKZ GSN CSPG4 | 3.68e-06 | 500 | 191 | 17 | GO:0031252 |
| GeneOntologyCellularComponent | site of polarized growth | MYO1A MYO5A USP9X DISC1 MAPK8IP3 IQGAP1 PREX1 PPP1R9A FRY PARD3 NIN | 2.23e-05 | 253 | 191 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | growth cone | MYO1A MYO5A USP9X DISC1 MAPK8IP3 IQGAP1 PREX1 PPP1R9A PARD3 NIN | 8.95e-05 | 245 | 191 | 10 | GO:0030426 |
| GeneOntologyCellularComponent | supramolecular fiber | KIF18A MYH11 MYO1A IQGAP2 MYO5A DISC1 SPTBN1 APC2 GFAP IQGAP1 KLHL21 SYNE2 MTCL1 JAKMIP1 DNAH9 MYO18A WHAMM HID1 GSN NARF CST2 TEKT4 HCK NIN | 1.98e-04 | 1179 | 191 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF18A MYH11 MYO1A IQGAP2 MYO5A DISC1 SPTBN1 APC2 GFAP IQGAP1 KLHL21 SYNE2 MTCL1 JAKMIP1 DNAH9 MYO18A WHAMM HID1 GSN NARF CST2 TEKT4 HCK NIN | 2.19e-04 | 1187 | 191 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | vacuole | MANBA MYO5A MYO7A HLA-DQB2 ACP2 HLA-DRB3 HLA-DRB5 WDR81 GFAP TINAG RAB24 PTGES2 TPCN2 ANXA11 OCRL ENTPD4 MST1R FRK CSPG4 HCK | 2.74e-04 | 913 | 191 | 20 | GO:0005773 |
| GeneOntologyCellularComponent | lamellipodium | 2.76e-04 | 230 | 191 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 3.21e-04 | 141 | 191 | 7 | GO:0005793 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 4.65e-04 | 17 | 191 | 3 | GO:0042613 | |
| GeneOntologyCellularComponent | lysosome | MANBA MYO5A MYO7A HLA-DQB2 ACP2 HLA-DRB3 HLA-DRB5 WDR81 GFAP TINAG PTGES2 TPCN2 ANXA11 OCRL ENTPD4 FRK CSPG4 HCK | 4.79e-04 | 811 | 191 | 18 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | MANBA MYO5A MYO7A HLA-DQB2 ACP2 HLA-DRB3 HLA-DRB5 WDR81 GFAP TINAG PTGES2 TPCN2 ANXA11 OCRL ENTPD4 FRK CSPG4 HCK | 4.79e-04 | 811 | 191 | 18 | GO:0000323 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF18A MYO1A IQGAP2 MYO5A DISC1 APC2 GFAP IQGAP1 KLHL21 MTCL1 JAKMIP1 DNAH9 WHAMM HID1 GSN NARF TEKT4 HCK NIN | 6.05e-04 | 899 | 191 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | cell cortex | MYO1A IQGAP2 MYO7A SPTBN1 IQGAP1 EXOC3L4 PPP1R9A GSN FRY PARD3 EPB41 | 6.38e-04 | 371 | 191 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.02e-03 | 22 | 191 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.21e-03 | 129 | 191 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | microtubule | KIF18A IQGAP2 DISC1 APC2 IQGAP1 KLHL21 MTCL1 JAKMIP1 DNAH9 WHAMM HID1 TEKT4 NIN | 1.28e-03 | 533 | 191 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | inclusion body | 1.42e-03 | 90 | 191 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.64e-03 | 93 | 191 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.67e-03 | 26 | 191 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | lateral loop | 1.69e-03 | 7 | 191 | 2 | GO:0043219 | |
| GeneOntologyCellularComponent | microtubule organizing center | KIF18A HK2 USP9X DISC1 KIZ CCDC88B FBXW8 NDC80 HERC2 TSGA10IP EEF1AKMT3 MYO18A LCK FRY CEP131 CCDC65 TP53 NIN | 1.97e-03 | 919 | 191 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.24e-03 | 8 | 191 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | distal axon | MYO1A MYO5A USP9X DISC1 MAPK8IP3 IQGAP1 PREX1 POLG PPP1R9A PARD3 NIN | 2.27e-03 | 435 | 191 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 2.87e-03 | 9 | 191 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.87e-03 | 9 | 191 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | endocytic vesicle | HLA-DQB2 INPP5B HLA-DRB3 HLA-DRB5 ANXA11 MYO18A OCRL LCK GSN RABEP1 | 2.89e-03 | 384 | 191 | 10 | GO:0030139 |
| MousePheno | increased hepatocellular carcinoma incidence | 9.11e-07 | 70 | 153 | 8 | MP:0003331 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.92e-05 | 111 | 153 | 8 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 2.92e-05 | 111 | 153 | 8 | MP:0008019 | |
| MousePheno | abnormal Purkinje cell dendrite morphology | 3.94e-05 | 58 | 153 | 6 | MP:0008572 | |
| Domain | IQ | MYH11 MYO1A IQGAP2 MYO5A MYO7A MYO5C IQGAP1 MYO3B MYO18A CEP131 | 2.52e-09 | 71 | 190 | 10 | PF00612 |
| Domain | IQ | MYH11 MYO1A IQGAP2 MYO5A MYO7A MYO5C IQGAP1 MYO3B MYO18A CEP131 | 9.41e-09 | 81 | 190 | 10 | SM00015 |
| Domain | IQ_motif_EF-hand-BS | MYH11 MYO1A IQGAP2 MYO5A MYO7A MYO5C IQGAP1 MYO3B MYO18A CEP131 | 2.65e-08 | 90 | 190 | 10 | IPR000048 |
| Domain | IQ | MYH11 MYO1A IQGAP2 MYO5A MYO7A MYO5C IQGAP1 MYO3B MYO18A CEP131 | 3.64e-08 | 93 | 190 | 10 | PS50096 |
| Domain | Myosin_head_motor_dom | 9.76e-08 | 38 | 190 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 9.76e-08 | 38 | 190 | 7 | PS51456 | |
| Domain | Myosin_head | 9.76e-08 | 38 | 190 | 7 | PF00063 | |
| Domain | MYSc | 9.76e-08 | 38 | 190 | 7 | SM00242 | |
| Domain | PDZ | RHPN1 PREX1 CARD14 PPP1R9A MYO18A DVL3 PALS1 PALS2 PARD3 PDZRN3 | 2.83e-06 | 148 | 190 | 10 | SM00228 |
| Domain | - | RHPN1 PREX1 CARD14 PPP1R9A MYO18A DVL3 PALS1 PALS2 PARD3 PDZRN3 | 3.20e-06 | 150 | 190 | 10 | 2.30.42.10 |
| Domain | PDZ | RHPN1 PREX1 CARD14 PPP1R9A MYO18A DVL3 PALS1 PALS2 PARD3 PDZRN3 | 3.39e-06 | 151 | 190 | 10 | PS50106 |
| Domain | PDZ | RHPN1 PREX1 CARD14 PPP1R9A MYO18A DVL3 PALS1 PALS2 PARD3 PDZRN3 | 3.60e-06 | 152 | 190 | 10 | IPR001478 |
| Domain | Myosin_S1_N | 1.02e-05 | 5 | 190 | 3 | IPR008989 | |
| Domain | SPOC_C | 2.03e-05 | 6 | 190 | 3 | IPR012921 | |
| Domain | SPOC | 2.03e-05 | 6 | 190 | 3 | PF07744 | |
| Domain | Myosin-like_IQ_dom | 3.57e-05 | 19 | 190 | 4 | IPR027401 | |
| Domain | - | 3.57e-05 | 19 | 190 | 4 | 4.10.270.10 | |
| Domain | P-loop_NTPase | GIMAP4 KIF18A TRIT1 MYH11 ABCF3 MYO1A MYO5A MYO7A DHX38 MCM7 MYO5C IQGAP1 TRANK1 RAB24 MYO3B ABCD2 DNAH9 CARD14 ABCC1 MYO18A PALS1 PALS2 | 5.39e-05 | 848 | 190 | 22 | IPR027417 |
| Domain | MHC_II_b_N | 5.59e-05 | 8 | 190 | 3 | PD000328 | |
| Domain | MHC_II_b_N | 8.32e-05 | 9 | 190 | 3 | IPR000353 | |
| Domain | MHC_II_beta | 8.32e-05 | 9 | 190 | 3 | SM00921 | |
| Domain | MHC_II_beta | 8.32e-05 | 9 | 190 | 3 | PF00969 | |
| Domain | PDZ | 9.89e-05 | 141 | 190 | 8 | PF00595 | |
| Domain | Grip | 1.61e-04 | 11 | 190 | 3 | SM00755 | |
| Domain | GRIP | 1.61e-04 | 11 | 190 | 3 | PF01465 | |
| Domain | Ran_BP1 | 2.13e-04 | 12 | 190 | 3 | PF00638 | |
| Domain | RANBD1 | 2.13e-04 | 12 | 190 | 3 | PS50196 | |
| Domain | GRIP_dom | 2.13e-04 | 12 | 190 | 3 | IPR000237 | |
| Domain | GRIP | 2.13e-04 | 12 | 190 | 3 | PS50913 | |
| Domain | RanBD | 2.75e-04 | 13 | 190 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 2.75e-04 | 13 | 190 | 3 | IPR000156 | |
| Domain | RasGAP_C | 3.07e-04 | 3 | 190 | 2 | IPR000593 | |
| Domain | RasGAP_C | 3.07e-04 | 3 | 190 | 2 | PF03836 | |
| Domain | SUZ | 3.07e-04 | 3 | 190 | 2 | PF12752 | |
| Domain | SPOC_met | 3.07e-04 | 3 | 190 | 2 | IPR010912 | |
| Domain | MHC_II_a/b_N | 3.47e-04 | 14 | 190 | 3 | IPR014745 | |
| Domain | - | 3.47e-04 | 14 | 190 | 3 | 3.10.320.10 | |
| Domain | SH3 | 3.78e-04 | 216 | 190 | 9 | SM00326 | |
| Domain | SH3 | 3.78e-04 | 216 | 190 | 9 | PS50002 | |
| Domain | SH3_domain | 4.32e-04 | 220 | 190 | 9 | IPR001452 | |
| Domain | PH_dom-like | MYO7A NBEAL1 SPTBN1 RGPD1 PLEKHS1 FARP2 MCF2L PREX1 RGPD5 IRS4 RGPD8 ARHGEF18 EPB41 | 4.36e-04 | 426 | 190 | 13 | IPR011993 |
| Domain | DH_1 | 4.50e-04 | 63 | 190 | 5 | PS00741 | |
| Domain | SUZ | 6.09e-04 | 4 | 190 | 2 | IPR024771 | |
| Domain | SUZ | 6.09e-04 | 4 | 190 | 2 | PS51673 | |
| Domain | SPOC | 6.09e-04 | 4 | 190 | 2 | PS50917 | |
| Domain | RhoGEF | 6.41e-04 | 68 | 190 | 5 | SM00325 | |
| Domain | GDS_CDC24_CS | 6.46e-04 | 39 | 190 | 4 | IPR001331 | |
| Domain | RhoGEF | 7.32e-04 | 70 | 190 | 5 | PF00621 | |
| Domain | DH_2 | 7.32e-04 | 70 | 190 | 5 | PS50010 | |
| Domain | Myosin_tail_1 | 7.56e-04 | 18 | 190 | 3 | PF01576 | |
| Domain | Myosin_tail | 7.56e-04 | 18 | 190 | 3 | IPR002928 | |
| Domain | - | 7.82e-04 | 71 | 190 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 7.82e-04 | 71 | 190 | 5 | IPR000219 | |
| Domain | - | 1.01e-03 | 5 | 190 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 1.01e-03 | 5 | 190 | 2 | IPR016194 | |
| Domain | Dilute_dom | 1.50e-03 | 6 | 190 | 2 | IPR002710 | |
| Domain | DIL | 1.50e-03 | 6 | 190 | 2 | PF01843 | |
| Domain | DILUTE | 1.50e-03 | 6 | 190 | 2 | PS51126 | |
| Domain | DIL | 1.50e-03 | 6 | 190 | 2 | SM01132 | |
| Domain | Spectrin | 1.58e-03 | 23 | 190 | 3 | PF00435 | |
| Domain | GUANYLATE_KINASE_2 | 1.58e-03 | 23 | 190 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.58e-03 | 23 | 190 | 3 | PS00856 | |
| Domain | Protein_kinase_ATP_BS | 1.78e-03 | 379 | 190 | 11 | IPR017441 | |
| Domain | WW_DOMAIN_1 | 1.79e-03 | 51 | 190 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 1.79e-03 | 51 | 190 | 4 | PS50020 | |
| Domain | WW_dom | 1.92e-03 | 52 | 190 | 4 | IPR001202 | |
| Domain | Rab_bind | 2.09e-03 | 7 | 190 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.09e-03 | 7 | 190 | 2 | IPR032023 | |
| Domain | Guanylate_kin | 2.27e-03 | 26 | 190 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.27e-03 | 26 | 190 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.27e-03 | 26 | 190 | 3 | IPR008144 | |
| Domain | GuKc | 2.27e-03 | 26 | 190 | 3 | SM00072 | |
| Domain | - | MYO7A SPTBN1 RGPD1 PLEKHS1 FARP2 MCF2L PREX1 IRS4 RGPD8 ARHGEF18 EPB41 | 2.27e-03 | 391 | 190 | 11 | 2.30.29.30 |
| Domain | HECT | 2.53e-03 | 27 | 190 | 3 | PF00632 | |
| Domain | HECTc | 2.53e-03 | 27 | 190 | 3 | SM00119 | |
| Domain | HECT_dom | 2.53e-03 | 27 | 190 | 3 | IPR000569 | |
| Domain | HECT | 2.53e-03 | 27 | 190 | 3 | PS50237 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KIF18A MYH11 MYLK EPSTI1 IQGAP2 USP9X SPTBN1 RGPD1 IQGAP1 FARP2 RHPN1 NDC80 MCF2L DNMBP PREX1 RGPD8 DVL3 WHAMM ARHGEF18 OCRL LCK CPSF7 | 6.85e-07 | 649 | 144 | 22 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | EPSTI1 IQGAP2 USP9X SPTBN1 WDR81 IQGAP1 FARP2 RHPN1 MCF2L DNMBP PREX1 UACA WHAMM ARHGEF18 OCRL LCK CPSF7 | 3.42e-06 | 450 | 144 | 17 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KIF18A MYH11 MYLK EPSTI1 IQGAP2 USP9X SPTBN1 WDR81 IQGAP1 FARP2 RHPN1 NDC80 MCF2L DNMBP PREX1 UACA DVL3 WHAMM ARHGEF18 OCRL LCK CPSF7 | 3.79e-06 | 720 | 144 | 22 | M41838 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | EPSTI1 IQGAP2 USP9X SPTBN1 IQGAP1 FARP2 RHPN1 MCF2L DNMBP PREX1 WHAMM ARHGEF18 OCRL LCK CPSF7 | 4.29e-05 | 439 | 144 | 15 | MM15595 |
| Pubmed | HECW1 IQGAP2 MYO5A USP9X SPTBN1 APC2 RGPD1 WDR81 PGAM5 MAPK8IP3 IQGAP1 ZNF394 SYNE2 MTCL1 JAKMIP1 HERC2 GOLGB1 RGPD8 UACA PPP1R9A ARHGEF18 DIDO1 DGKZ WDR26 GSN STRIP1 PALS1 FRY RABEP1 SAFB2 CEP131 PARD3 | 5.78e-16 | 963 | 195 | 32 | 28671696 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | IQGAP2 MYO5A USP9X LAMA1 MCM7 FARP2 BMPR1A PELO RBM15B HERC2 RBM15 ZCCHC8 WWP1 PARD3 TP53 | 3.39e-10 | 313 | 195 | 15 | 38270169 |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | KIF18A USP9X MCM7 PGAM5 PPP1R9A DVL3 WDR26 GSN STRIP1 PALS1 RABEP1 PALS2 PARD3 STK38L | 4.83e-10 | 270 | 195 | 14 | 24366813 |
| Pubmed | USP9X PGAM5 CRLF3 CGN MTCL1 RBM15 IRS4 ZCCHC8 PPP1R9A STRIP1 PALS1 RABEP1 CEP131 R3HDM1 PARD3 STK38L NIN | 7.35e-10 | 446 | 195 | 17 | 24255178 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ACACA SPTBN1 MAPK8IP3 IQGAP1 SAFB RBM15B ZBTB40 DNMBP UBE2E3 HOMEZ RBM15 ATN1 UACA ZCCHC8 MYO18A DIDO1 STRIP1 ZNF106 SAFB2 PARD3 PHF10 | 3.17e-09 | 774 | 195 | 21 | 15302935 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | HECW1 HLA-DRB5 APC2 CCDC88B GFAP MAPK8IP3 JAG2 FBXO7 KAZN JAKMIP1 ATN1 RGPD8 PUF60 WWP1 DVL3 SAFB2 R3HDM1 TP53 | 3.36e-09 | 560 | 195 | 18 | 21653829 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5A USP9X PACSIN3 MCM7 URB2 PGAM5 MYO5C IQGAP1 FBXW8 SAFB SYNE2 CGN HERC2 GOLGB1 RBM15 IRS4 PUF60 PPP1R9A ANXA11 GSN SAFB2 CEP131 TP53 CPSF7 | 3.91e-09 | 1024 | 195 | 24 | 24711643 |
| Pubmed | 7.90e-09 | 104 | 195 | 9 | 9205841 | ||
| Pubmed | ACACA PDK1 PACSIN3 ITGA7 CEMIP2 FARP2 GOLGB1 ABCC1 IRS4 UACA PPP1R9A OCRL PALS1 PALS2 PARD3 | 1.87e-08 | 421 | 195 | 15 | 36976175 | |
| Pubmed | ACACA MYO5A USP9X SPTBN1 DHX38 URB2 PGAM5 IQGAP1 SYNE2 CGN HERC2 RBM15 IRS4 PUF60 ZCCHC8 ANXA11 DIDO1 TP53 | 3.53e-08 | 653 | 195 | 18 | 22586326 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CWF19L2 USP9X DHX38 MCM7 PGAM5 PELO NDC80 DNMBP GOLGB1 RBM15 RGPD8 ZCCHC8 RABEP1 CEP131 TP53 CPSF7 NIN | 4.36e-08 | 588 | 195 | 17 | 38580884 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO5A PDK1 EXOSC5 URB2 JAKMIP1 HERC2 GOLGB1 ABCC1 PTGES2 UACA PEX3 MYO18A WDR26 GSN SNIP1 CEP131 R3HDM1 TP53 NIN | 5.93e-08 | 754 | 195 | 19 | 33060197 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ACACA SPTBN1 HJURP SYNE2 CGN MTCL1 DNMBP GOLGB1 RBM15 IRS4 ZCCHC8 LCK WDR26 ZNF106 RABEP1 CEP131 R3HDM1 PARD3 EPB41 TP53 | 9.76e-08 | 861 | 195 | 20 | 36931259 |
| Pubmed | ACACA USP9X MCM7 PGAM5 CGN RGPD5 IRS4 PUF60 DIDO1 PALS1 MTRF1 RNF2 RABEP1 PARD3 EPB41 TP53 | 9.91e-08 | 549 | 195 | 16 | 38280479 | |
| Pubmed | MYH11 MYLK MYO1A IQGAP2 MYO5A SPTBN1 RGPD1 PGAM5 IQGAP1 BMPR1A SAFB SYNE2 JAKMIP1 MCF2L PREX1 GOLGB1 RGPD5 IRS4 RGPD8 PCDHGC5 PPP1R9A MYO18A RNF2 CSPG4 SAFB2 PCDHGC3 | 1.64e-07 | 1442 | 195 | 26 | 35575683 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 31486135 | ||
| Pubmed | SPTBN1 PGAM5 FARP2 CGN JAKMIP1 IRS4 PUF60 RABEP1 PARD3 STK38L TP53 | 2.36e-07 | 255 | 195 | 11 | 15324660 | |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 2.44e-07 | 112 | 195 | 8 | 20473970 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ACACA MYO5A KIZ TSPYL2 TMEM63B NSRP1 MAPK8IP3 FARP2 JAG2 TMX3 MCF2L UBE2E3 GOLGB1 UBR2 TPCN2 UACA WWP1 POLG PPP1R9A ARHGEF18 NACC2 RABEP1 PALS2 PARD3 STK38L EPB41 | 3.03e-07 | 1489 | 195 | 26 | 28611215 |
| Pubmed | ABCF3 ACACA MATN2 SPTBN1 MCM7 PGAM5 IQGAP1 BMPR1A PELO CGN OXSM UBR2 RBM15 ATN1 UACA PUF60 WWP1 DVL3 PALS1 RNF2 WDR87 PARD3 CPSF7 | 6.11e-07 | 1247 | 195 | 23 | 27684187 | |
| Pubmed | SAFB1 interacts with and suppresses the transcriptional activity of p53. | 6.91e-07 | 4 | 195 | 3 | 21130767 | |
| Pubmed | ACACA RGPD1 MCM7 GOLGB1 HOMEZ IRS4 RGPD8 LCORL ZCCHC8 DVL3 WDR26 RABEP1 CEP131 | 7.92e-07 | 418 | 195 | 13 | 34709266 | |
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 8022818 | ||
| Pubmed | MYO5A USP9X SPTBN1 APC2 TSPYL2 ZNF202 GFAP MAPK8IP3 IQGAP1 FBXO7 JAKMIP1 HERC2 PREX1 PTGES2 ZCCHC8 POLG DVL3 WHAMM WDR26 FRY RABEP1 PALS2 R3HDM1 | 1.02e-06 | 1285 | 195 | 23 | 35914814 | |
| Pubmed | SPTBN1 NSRP1 IQGAP1 SAFB CGN GOLGB1 RBM15 PPP1R9A DIDO1 GSN RABEP1 CPSF7 | 1.03e-06 | 360 | 195 | 12 | 33111431 | |
| Pubmed | MYO5A CLK4 DHX38 PACSIN3 EXOSC5 URB2 IQGAP1 FARP2 RBM15B HERC2 DNMBP PREX1 GOLGB1 UACA ZCCHC8 PPP1R9A WHAMM DIDO1 DGKZ STRIP1 SNIP1 RNF2 CEP131 PARD3 EPB41 | 1.17e-06 | 1497 | 195 | 25 | 31527615 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.88e-06 | 197 | 195 | 9 | 20811636 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH11 MYO5A MATN2 SPTBN1 MCM7 PGAM5 NSRP1 MYO5C IQGAP1 SAFB RBM15 UACA PUF60 PPP1R9A MYO18A GSN SNIP1 SAFB2 EPB41 | 1.90e-06 | 949 | 195 | 19 | 36574265 |
| Pubmed | HK2 ACACA HECW1 MATN2 TSPYL2 JAG2 KAZN UBE2E3 ATN1 PUF60 WWP1 MYO18A R3HDM1 TP53 CPSF7 | 2.01e-06 | 608 | 195 | 15 | 16713569 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | USP9X CLK4 LAMA1 WDR81 MCM7 EXOSC5 NSRP1 IQGAP1 HERC2 RBM15 ZCCHC8 DIDO1 MKNK1 FRY PRKG2 TP53 | 2.22e-06 | 695 | 195 | 16 | 23602568 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.31e-06 | 202 | 195 | 9 | 33005030 | |
| Pubmed | 2.76e-06 | 18 | 195 | 4 | 12799088 | ||
| Pubmed | HK2 ABCF3 ACACA USP9X DHX38 MCM7 PGAM5 SAFB PELO RBM15 PUF60 LCK SAFB2 PALS2 CPSF7 | 4.77e-06 | 653 | 195 | 15 | 33742100 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | HJURP MCM7 PGAM5 FBXW8 NDC80 KLHL21 FBXO7 RC3H2 ATN1 DIDO1 RNF2 CST2 TP53 | 5.05e-06 | 495 | 195 | 13 | 27705803 |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 5.98e-06 | 7 | 195 | 3 | 15710750 | |
| Pubmed | Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen. | 9.09e-06 | 50 | 195 | 5 | 24721909 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 9.23e-06 | 130 | 195 | 7 | 35545047 | |
| Pubmed | 9.52e-06 | 8 | 195 | 3 | 22006950 | ||
| Pubmed | MYH11 IQGAP2 SPTBN1 PACSIN3 PGAM5 IQGAP1 CGN RBM15B HERC2 RC3H2 RBM15 UACA PUF60 DIDO1 C2orf68 SNIP1 RNF2 CEP131 PARD3 PHF10 TP53 CPSF7 | 1.01e-05 | 1371 | 195 | 22 | 36244648 | |
| Pubmed | 1.07e-05 | 133 | 195 | 7 | 15144186 | ||
| Pubmed | ABCF3 IQGAP2 INPP5B SPTBN1 DHX38 HJURP BMPR1A EXOC3L4 FBXO7 ZBTB40 TMX3 GOLGB1 WWP1 POLG ARHGEF18 DIDO1 DGKZ SAFB2 PARD3 | 1.26e-05 | 1084 | 195 | 19 | 11544199 | |
| Pubmed | 1.42e-05 | 9 | 195 | 3 | 7842732 | ||
| Pubmed | 1.59e-05 | 56 | 195 | 5 | 22745667 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYO1A DHX38 PGAM5 IQGAP1 SAFB FBXO7 PKLR MTCL1 HERC2 TMX3 RGPD5 RBM15 PPP1R9A WDR26 STRIP1 PALS1 TP53 NIN | 1.62e-05 | 1005 | 195 | 18 | 19615732 |
| Pubmed | 2.02e-05 | 10 | 195 | 3 | 32450295 | ||
| Pubmed | 2.04e-05 | 29 | 195 | 4 | 15078178 | ||
| Pubmed | 2.09e-05 | 99 | 195 | 6 | 27746211 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYO5A MYO7A SPTBN1 HLA-DRB5 PACSIN3 FARP2 ZNF394 KLHL21 CRLF3 FBXO7 KAZN MCF2L HOMEZ PTGES2 ADAMTS3 PEX3 ARHGEF18 SNIP1 ZNF106 NACC2 | 2.49e-05 | 1242 | 195 | 20 | 30973865 |
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 2.62e-05 | 103 | 195 | 6 | 22623531 | |
| Pubmed | 2.67e-05 | 274 | 195 | 9 | 34244482 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 2.73e-05 | 211 | 195 | 8 | 17314511 | |
| Pubmed | KIF18A MYO5A USP9X SPTBN1 DHX38 CEMIP2 CRLF3 SYNE2 CGN HERC2 UBR2 ABCC1 RBM15 IRS4 PPP1R9A HID1 CEP131 NIN | 2.84e-05 | 1049 | 195 | 18 | 27880917 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KIZ DHX38 HJURP RGPD1 TMEM63B PACSIN3 IQGAP1 BMPR1A NDC80 MTCL1 HERC2 RGPD5 RGPD8 UACA LCK STRIP1 ZNF106 CEP131 PHF10 | 3.00e-05 | 1155 | 195 | 19 | 20360068 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ABCF3 ACACA USP9X SPTBN1 PACSIN3 MCM7 IQGAP1 SAFB PELO SYNE2 UBE2E3 GOLGB1 PUF60 ANXA11 MYO18A DVL3 MUC5B GSN CST2 EPB41 CPSF7 | 3.07e-05 | 1367 | 195 | 21 | 32687490 |
| Pubmed | Overexpression of myosin is associated with the development of uterine myoma. | 3.13e-05 | 2 | 195 | 2 | 25181625 | |
| Pubmed | DGKζ ablation engenders upregulation of p53 level in the spleen upon whole-body ionizing radiation. | 3.13e-05 | 2 | 195 | 2 | 29079355 | |
| Pubmed | Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1. | 3.13e-05 | 2 | 195 | 2 | 16924229 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 17437012 | ||
| Pubmed | Cytoplasmic localization of DGKζ exerts a protective effect against p53-mediated cytotoxicity. | 3.13e-05 | 2 | 195 | 2 | 23606744 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 9705913 | ||
| Pubmed | X-inactivation analysis of embryonic lethality in Ocrl wt/-; Inpp5b-/- mice. | 3.13e-05 | 2 | 195 | 2 | 20195868 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 10364375 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 21695055 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 9593760 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 37907523 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 6547441 | ||
| Pubmed | Identification of IQGAP1 as a SLC26A4 (Pendrin)-Binding Protein in the Kidney. | 3.13e-05 | 2 | 195 | 2 | 35601831 | |
| Pubmed | IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. | 3.13e-05 | 2 | 195 | 2 | 20977743 | |
| Pubmed | SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells. | 3.13e-05 | 2 | 195 | 2 | 19901029 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 25742798 | ||
| Pubmed | Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. | 3.13e-05 | 2 | 195 | 2 | 18180285 | |
| Pubmed | Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy. | 3.13e-05 | 2 | 195 | 2 | 21183592 | |
| Pubmed | Low SAFB levels are associated with worse outcome in breast cancer patients. | 3.13e-05 | 2 | 195 | 2 | 19137425 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 19700499 | ||
| Pubmed | Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin. | 3.13e-05 | 2 | 195 | 2 | 26912658 | |
| Pubmed | Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells. | 3.13e-05 | 2 | 195 | 2 | 26273616 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 26092125 | ||
| Pubmed | Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice. | 3.13e-05 | 2 | 195 | 2 | 29029019 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 14587024 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 33450306 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 23292286 | ||
| Pubmed | Pendred Syndrome, or Not Pendred Syndrome? That Is the Question. | 3.13e-05 | 2 | 195 | 2 | 34680964 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 17982131 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 23601552 | ||
| Pubmed | LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients. | 3.13e-05 | 2 | 195 | 2 | 25595912 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 22529380 | ||
| Pubmed | Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome. | 3.13e-05 | 2 | 195 | 2 | 27869650 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 21106733 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 11784089 | ||
| Pubmed | Human myosin-Vc is a novel class V myosin expressed in epithelial cells. | 3.13e-05 | 2 | 195 | 2 | 11870218 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 12776191 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 22566185 | ||
| Pubmed | Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. | 3.13e-05 | 2 | 195 | 2 | 8171035 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 24722987 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 24998570 | ||
| Pubmed | Myosin Va is required for normal photoreceptor synaptic activity. | 3.13e-05 | 2 | 195 | 2 | 15316067 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 22105368 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 25305077 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 5449211 | ||
| Pubmed | Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy. | 3.13e-05 | 2 | 195 | 2 | 27895154 | |
| Interaction | TJP2 interactions | ACACA DISC1 MCM7 EXOSC5 PGAM5 ZUP1 IQGAP1 SAFB CGN DNMBP WWP1 MYO18A DVL3 PARD3 EPB41 | 1.36e-07 | 288 | 194 | 15 | int:TJP2 |
| Interaction | DVL2 interactions | CWF19L2 ACACA EAF2 USP9X MCM7 PGAM5 IQGAP1 PKLR ATN1 EEF1AKMT3 WWP1 DVL3 WDR26 MST1R SNIP1 PARD3 HCK TP53 CPSF7 | 1.98e-06 | 557 | 194 | 19 | int:DVL2 |
| Interaction | AMOT interactions | USP9X DISC1 NDC80 CGN FBXO7 MTCL1 DNMBP WWP1 LCK PALS1 CEP131 PALS2 PARD3 NIN | 2.12e-06 | 312 | 194 | 14 | int:AMOT |
| Interaction | CHMP4B interactions | KIF18A MYH11 ACACA NBEAL1 USP9X SPTBN1 TMEM63B PACSIN3 PGAM5 GFAP IQGAP1 HERC2 GOLGB1 TRPV1 PUF60 PPP1R9A LCK GSN SAFB2 PALS2 TP53 CPSF7 | 2.13e-06 | 727 | 194 | 22 | int:CHMP4B |
| Interaction | YAP1 interactions | MYH11 ACACA MYO1A HECW1 USP9X SPTBN1 APC2 TSPYL2 MCM7 PGAM5 GFAP IQGAP1 MYO3B PKLR IRS4 ATN1 UACA WWP1 DIDO1 GSN FRK PALS1 RNF2 RABEP1 PARD3 EPB41 TP53 CPSF7 | 2.22e-06 | 1095 | 194 | 28 | int:YAP1 |
| Interaction | FBXO25 interactions | MYH11 MYO1A MYO5A MCM7 GFAP NSRP1 IQGAP1 UBE2E3 UACA GSN PRKG2 | 3.59e-06 | 198 | 194 | 11 | int:FBXO25 |
| Interaction | CDC42 interactions | MYLK ACACA IQGAP2 USP9X SPTBN1 PACSIN3 WDR81 MCM7 URB2 CEMIP2 IQGAP1 BMPR1A SYNE2 CGN HERC2 MCF2L DNMBP PREX1 GOLGB1 ABCC1 FAM89A IRS4 PPP1R9A ANXA11 MYO18A MUC12 OCRL LCK CSPG4 PARD3 TP53 | 3.66e-06 | 1323 | 194 | 31 | int:CDC42 |
| Interaction | DHX40 interactions | CWF19L2 DHX38 NSRP1 SAFB FBXO7 RBM15 ZCCHC8 ZNF106 GPSM3 TP53 CPSF7 NIN | 5.60e-06 | 249 | 194 | 12 | int:DHX40 |
| Interaction | IGFL3 interactions | 7.85e-06 | 75 | 194 | 7 | int:IGFL3 | |
| Interaction | CTTN interactions | MYLK MYO5A SPTBN1 NSRP1 MYO5C IQGAP1 NDC80 RBM15B RBM15 PPP1R9A MYO18A GSN STRIP1 SNIP1 CPSF7 NIN | 7.88e-06 | 450 | 194 | 16 | int:CTTN |
| Interaction | YWHAG interactions | DISC1 ACP2 SPTBN1 HJURP PGAM5 IQGAP1 FARP2 SYNE2 CGN RBM15B MTCL1 JAKMIP1 DNMBP HOMEZ RC3H2 RBM15 IRS4 UACA PUF60 MST1R SNIP1 ZNF106 RABEP1 GPSM3 CEP131 R3HDM1 PARD3 EPB41 TP53 | 9.21e-06 | 1248 | 194 | 29 | int:YWHAG |
| Interaction | GAGE5 interactions | 1.04e-05 | 52 | 194 | 6 | int:GAGE5 | |
| Interaction | UQCR11 interactions | 1.16e-05 | 53 | 194 | 6 | int:UQCR11 | |
| Interaction | ARRDC3 interactions | IQGAP2 USP9X MCM7 FARP2 BMPR1A RBM15B UBE2E3 RBM15 ZCCHC8 WWP1 PARD3 | 1.16e-05 | 224 | 194 | 11 | int:ARRDC3 |
| Interaction | PECR interactions | 1.28e-05 | 32 | 194 | 5 | int:PECR | |
| Interaction | SAA1 interactions | 1.30e-05 | 54 | 194 | 6 | int:SAA1 | |
| Interaction | PSENEN interactions | 1.31e-05 | 81 | 194 | 7 | int:PSENEN | |
| Interaction | LIMA1 interactions | MYO5A DISC1 SPTBN1 PACSIN3 PGAM5 MYO5C IQGAP1 CGN TRPV1 ZCCHC8 PPP1R9A MYO18A GSN RNF2 TP53 | 1.86e-05 | 429 | 194 | 15 | int:LIMA1 |
| Interaction | YWHAH interactions | MYH11 SPTBN1 DHX38 HJURP IQGAP1 SYNE2 CGN RBM15B MTCL1 JAKMIP1 DNMBP HOMEZ RBM15 IRS4 UACA ZCCHC8 WDR26 MST1R ZNF106 RABEP1 GPSM3 CEP131 R3HDM1 PARD3 EPB41 NIN | 2.17e-05 | 1102 | 194 | 26 | int:YWHAH |
| Interaction | YWHAZ interactions | MYH11 MYO5A DISC1 SPTBN1 HJURP GFAP SYNE2 CGN JAKMIP1 HERC2 DNMBP HOMEZ RBM15 IRS4 UACA PUF60 MYO18A ARHGEF18 LCK GSN MST1R RABEP1 GPSM3 CEP131 R3HDM1 PARD3 EPB41 TP53 NIN | 2.59e-05 | 1319 | 194 | 29 | int:YWHAZ |
| Interaction | MAD2L1BP interactions | 2.63e-05 | 61 | 194 | 6 | int:MAD2L1BP | |
| Interaction | EXOSC9 interactions | 2.81e-05 | 162 | 194 | 9 | int:EXOSC9 | |
| Interaction | NEXN interactions | 2.81e-05 | 91 | 194 | 7 | int:NEXN | |
| Interaction | KIF20A interactions | MYH11 MYO1A INPP5B SPTBN1 APC2 PACSIN3 PGAM5 GFAP SAFB MYO3B SYNE2 CGN HERC2 RGPD8 UACA PUF60 PPP1R9A MYO18A DIDO1 ZNF106 RNF2 RABEP1 SAFB2 PARD3 TP53 | 2.82e-05 | 1052 | 194 | 25 | int:KIF20A |
| Interaction | MYO5A interactions | 2.96e-05 | 204 | 194 | 10 | int:MYO5A | |
| Interaction | FXR1 interactions | CWF19L2 USP9X HLA-DRB5 APC2 GFAP MAPK8IP3 KAZN JAKMIP1 HERC2 GOLGB1 RC3H2 ATN1 DIDO1 OCRL SAFB2 GPSM3 R3HDM1 HCK TP53 | 3.24e-05 | 679 | 194 | 19 | int:FXR1 |
| Interaction | ANAPC15 interactions | 3.41e-05 | 128 | 194 | 8 | int:ANAPC15 | |
| Interaction | NXF1 interactions | ABCF3 EFCAB11 ACACA DISC1 SPTBN1 DHX38 HJURP RGPD1 WDR81 MCM7 GFAP IQGAP1 ZSCAN29 NDC80 RBM15B MTCL1 HOMEZ RGPD5 RBM15 PEX3 MYO18A DVL3 OCRL STRIP1 TMED3 ZNF106 NANS TP53 CPSF7 | 3.69e-05 | 1345 | 194 | 29 | int:NXF1 |
| Interaction | IFI27L1 interactions | 3.79e-05 | 65 | 194 | 6 | int:IFI27L1 | |
| Interaction | RAB35 interactions | IQGAP2 MYO5A SPTBN1 CEMIP2 IQGAP1 JAG2 SYNE2 GOLGB1 ABCC1 TRPV1 IRS4 UACA PPP1R9A OCRL PALS1 PARD3 EPB41 | 4.17e-05 | 573 | 194 | 17 | int:RAB35 |
| Interaction | CASQ2 interactions | 4.51e-05 | 67 | 194 | 6 | int:CASQ2 | |
| Interaction | C11orf52 interactions | IQGAP2 SPTBN1 CEMIP2 IQGAP1 FARP2 JAG2 ABCC1 IRS4 UACA PALS2 PARD3 EPB41 | 5.08e-05 | 311 | 194 | 12 | int:C11orf52 |
| Interaction | NDC80 interactions | KIZ PGAM5 NSRP1 MYO5C NDC80 SYNE2 MTCL1 HERC2 UACA CEP131 CPSF7 NIN | 5.24e-05 | 312 | 194 | 12 | int:NDC80 |
| Interaction | UACA interactions | 5.25e-05 | 136 | 194 | 8 | int:UACA | |
| Interaction | PTPN14 interactions | 5.61e-05 | 177 | 194 | 9 | int:PTPN14 | |
| Interaction | WWTR1 interactions | MCM7 PGAM5 CGN RGPD5 IRS4 PUF60 DVL3 DIDO1 PALS1 MTRF1 RABEP1 PARD3 EPB41 TP53 | 6.25e-05 | 422 | 194 | 14 | int:WWTR1 |
| Interaction | UBE2D2 interactions | HECW1 USP9X ACOX1 FBXO7 HERC2 UBR2 RC3H2 WWP1 DVL3 RNF2 PDZRN3 TP53 | 6.29e-05 | 318 | 194 | 12 | int:UBE2D2 |
| Interaction | MATR3 interactions | ACACA USP9X DISC1 ZUP1 IQGAP1 SAFB FBXO7 RBM15B HERC2 RC3H2 PUF60 ZCCHC8 WWP1 SNIP1 ZNF106 RNF2 SAFB2 TP53 | 6.63e-05 | 655 | 194 | 18 | int:MATR3 |
| Interaction | EPHA2 interactions | ACACA PDK1 PACSIN3 ITGA7 CEMIP2 FARP2 PKLR GOLGB1 ABCC1 IRS4 UACA PPP1R9A OCRL LCK PALS1 PALS2 PARD3 HCK TP53 | 6.96e-05 | 719 | 194 | 19 | int:EPHA2 |
| Interaction | KHDRBS1 interactions | MYO7A DISC1 MATN2 DHX38 PACSIN3 DNMBP RC3H2 RBM15 LCK FRK RNF2 PALS2 HCK | 7.00e-05 | 373 | 194 | 13 | int:KHDRBS1 |
| Interaction | CCDC88B interactions | 7.02e-05 | 45 | 194 | 5 | int:CCDC88B | |
| Interaction | CAPZA2 interactions | MYO5A SPTBN1 PACSIN3 MYO5C IQGAP1 CGN MTCL1 RC3H2 PPP1R9A MYO18A GSN MST1R FRK ZNF106 | 7.64e-05 | 430 | 194 | 14 | int:CAPZA2 |
| Interaction | PEX14 interactions | IQGAP2 ACOX1 MYO5C IQGAP1 SYNE2 PEX3 OCRL RABEP1 CEP131 STK38L | 1.04e-04 | 237 | 194 | 10 | int:PEX14 |
| Interaction | SYNPO interactions | 1.05e-04 | 192 | 194 | 9 | int:SYNPO | |
| Interaction | SIRT7 interactions | ACACA MYO5A USP9X SPTBN1 DHX38 MCM7 URB2 PGAM5 IQGAP1 SYNE2 CGN HERC2 RBM15 IRS4 PUF60 ZCCHC8 ANXA11 DIDO1 TP53 | 1.09e-04 | 744 | 194 | 19 | int:SIRT7 |
| Interaction | AMOTL2 interactions | 1.10e-04 | 151 | 194 | 8 | int:AMOTL2 | |
| Interaction | SSX2IP interactions | EAF2 ZNF202 MCM7 NDC80 HERC2 TSGA10IP DVL3 OCRL CEP131 TP53 NIN | 1.15e-04 | 288 | 194 | 11 | int:SSX2IP |
| Interaction | SKAP2 interactions | 1.29e-04 | 51 | 194 | 5 | int:SKAP2 | |
| Interaction | ECT2 interactions | CWF19L2 MYH11 MYO1A USP9X SPTBN1 PACSIN3 PGAM5 GFAP NSRP1 MYO5C IQGAP1 PELO EXOC3L4 DNAH9 PUF60 PPP1R9A MYO18A GSN PARD3 TP53 CPSF7 | 1.35e-04 | 887 | 194 | 21 | int:ECT2 |
| Interaction | RHOD interactions | MYO5A USP9X SPTBN1 PACSIN3 CEMIP2 IQGAP1 JAG2 SYNE2 GOLGB1 ABCC1 IRS4 PPP1R9A MYO18A OCRL PARD3 EPB41 | 1.39e-04 | 572 | 194 | 16 | int:RHOD |
| Interaction | RICTOR interactions | HK2 MYO5A USP9X SPTBN1 RGPD1 NSRP1 ZUP1 IQGAP1 PELO PREX1 RGPD5 RGPD8 EEF1AKMT3 MYO18A LCK GSN RNF2 NANS EPB41 | 1.41e-04 | 759 | 194 | 19 | int:RICTOR |
| Interaction | MIB1 interactions | USP9X MCM7 PGAM5 JAG2 NDC80 IRS4 RGPD8 ZCCHC8 CEP131 TP53 NIN | 1.41e-04 | 295 | 194 | 11 | int:MIB1 |
| Interaction | TRIM27 interactions | CWF19L2 ABCF3 DISC1 RGPD1 MCM7 GFAP ZSCAN29 RHPN1 TSGA10IP UBE2E3 GOLGB1 RNF2 STK38L HCK TP53 | 1.43e-04 | 514 | 194 | 15 | int:TRIM27 |
| Interaction | WDR3 interactions | 1.64e-04 | 160 | 194 | 8 | int:WDR3 | |
| Interaction | TMOD1 interactions | 1.71e-04 | 161 | 194 | 8 | int:TMOD1 | |
| Interaction | LRRC31 interactions | 1.72e-04 | 205 | 194 | 9 | int:LRRC31 | |
| Interaction | YWHAQ interactions | MYH11 ACACA PDK1 DISC1 HJURP IQGAP1 BMPR1A FBXW8 CGN DNMBP GOLGB1 HOMEZ IRS4 UACA WWP1 LCK MST1R ZNF106 RABEP1 GPSM3 CEP131 R3HDM1 PARD3 EPB41 | 1.96e-04 | 1118 | 194 | 24 | int:YWHAQ |
| Interaction | TTC3 interactions | 2.00e-04 | 124 | 194 | 7 | int:TTC3 | |
| Interaction | DBN1 interactions | MYO5A DISC1 SPTBN1 PACSIN3 MYO5C IQGAP1 CGN HERC2 DNMBP PPP1R9A MYO18A GSN TP53 | 2.11e-04 | 417 | 194 | 13 | int:DBN1 |
| Interaction | CCDC8 interactions | MYO5A USP9X PACSIN3 MCM7 PGAM5 MYO5C IQGAP1 FBXW8 CGN HERC2 GOLGB1 IRS4 PPP1R9A ANXA11 LCK CEP131 TP53 | 2.13e-04 | 656 | 194 | 17 | int:CCDC8 |
| Interaction | MYO5C interactions | 2.28e-04 | 168 | 194 | 8 | int:MYO5C | |
| Interaction | INTS4P2 interactions | 2.34e-04 | 13 | 194 | 3 | int:INTS4P2 | |
| Interaction | LRRCC1 interactions | 2.42e-04 | 32 | 194 | 4 | int:LRRCC1 | |
| Interaction | PDLIM7 interactions | MYO5A SPTBN1 RGPD1 GFAP MYO5C IQGAP1 TSGA10IP WWP1 PARD3 TP53 | 2.50e-04 | 264 | 194 | 10 | int:PDLIM7 |
| Interaction | CALD1 interactions | DISC1 SPTBN1 MYO5C CGN PPP1R9A ANXA11 MYO18A MST1R PALS1 TP53 | 2.58e-04 | 265 | 194 | 10 | int:CALD1 |
| Interaction | EZH1 interactions | 2.64e-04 | 92 | 194 | 6 | int:EZH1 | |
| Interaction | ACTA1 interactions | MYLK MYO7A APC2 IQGAP1 CRLF3 DNMBP RC3H2 MYO18A GSN MTRF1 EPB41 TP53 | 2.65e-04 | 371 | 194 | 12 | int:ACTA1 |
| Interaction | TFIP11 interactions | CWF19L2 EAF2 DISC1 KIZ MCM7 EXOSC5 GFAP IQGAP1 NDC80 HERC2 TSGA10IP TP53 CPSF7 | 2.66e-04 | 427 | 194 | 13 | int:TFIP11 |
| Interaction | SHMT2 interactions | MYLK ACACA PDK1 DHX38 HJURP WDR81 ZUP1 BMPR1A DNAJC28 NDC80 FBXO7 PREX1 MYO18A STRIP1 MTRF1 NANS CPSF7 | 2.78e-04 | 671 | 194 | 17 | int:SHMT2 |
| Interaction | BIVM interactions | 2.96e-04 | 14 | 194 | 3 | int:BIVM | |
| Interaction | WWC1 interactions | 2.97e-04 | 94 | 194 | 6 | int:WWC1 | |
| Interaction | LINC02910 interactions | 3.15e-04 | 95 | 194 | 6 | int:LINC02910 | |
| Interaction | YWHAB interactions | SPTBN1 HJURP IQGAP1 CGN MTCL1 JAKMIP1 DNMBP HOMEZ RC3H2 IRS4 UACA ZCCHC8 MST1R ZNF106 RABEP1 GPSM3 CEP131 R3HDM1 PARD3 STK38L EPB41 TP53 | 3.18e-04 | 1014 | 194 | 22 | int:YWHAB |
| Interaction | MARK2 interactions | 3.36e-04 | 274 | 194 | 10 | int:MARK2 | |
| Interaction | CEP63 interactions | 3.51e-04 | 179 | 194 | 8 | int:CEP63 | |
| Interaction | CDK9 interactions | ACACA MYO5A SPTBN1 EXOSC5 NSRP1 IQGAP1 BMPR1A SAFB PELO NDC80 RBM15B MYO18A OCRL GSN HCK TP53 CPSF7 | 3.52e-04 | 685 | 194 | 17 | int:CDK9 |
| Interaction | OCLN interactions | IQGAP2 SPTBN1 CEMIP2 JAG2 CGN GOLGB1 ABCC1 IRS4 UACA PPP1R9A OCRL LCK PARD3 EPB41 | 3.62e-04 | 500 | 194 | 14 | int:OCLN |
| Interaction | CPAP interactions | 3.92e-04 | 182 | 194 | 8 | int:CPAP | |
| Interaction | DVL3 interactions | 3.99e-04 | 280 | 194 | 10 | int:DVL3 | |
| Interaction | TPCN2 interactions | 4.06e-04 | 65 | 194 | 5 | int:TPCN2 | |
| Interaction | NXF2 interactions | 4.06e-04 | 65 | 194 | 5 | int:NXF2 | |
| Interaction | PXN interactions | 4.10e-04 | 334 | 194 | 11 | int:PXN | |
| Interaction | CLTB interactions | 4.37e-04 | 185 | 194 | 8 | int:CLTB | |
| Interaction | LNX1 interactions | USP9X CLK4 TSPYL2 CCDC88B IQGAP1 NDC80 CGN KAZN HOMEZ WWP1 DVL3 LRRC3B TEKT4 PDZRN3 TP53 CPSF7 | 4.39e-04 | 634 | 194 | 16 | int:LNX1 |
| Interaction | RUNDC1 interactions | 4.48e-04 | 16 | 194 | 3 | int:RUNDC1 | |
| Interaction | YWHAE interactions | MYH11 DISC1 HLA-DRB3 HLA-DRB5 HJURP PGAM5 IQGAP1 CGN JAKMIP1 DNMBP UBR2 RC3H2 RBM15 IRS4 MST1R ZNF106 RABEP1 GPSM3 CEP131 R3HDM1 PARD3 STK38L EPB41 TP53 NIN | 4.49e-04 | 1256 | 194 | 25 | int:YWHAE |
| Interaction | MAPK9 interactions | 4.53e-04 | 186 | 194 | 8 | int:MAPK9 | |
| Interaction | RHOH interactions | MYO5A USP9X SPTBN1 PACSIN3 CEMIP2 PREX1 GOLGB1 ABCC1 IRS4 UACA MYO18A OCRL LCK PARD3 | 4.58e-04 | 512 | 194 | 14 | int:RHOH |
| Interaction | LZTS2 interactions | CWF19L2 EXOSC5 GFAP IQGAP1 RHPN1 CGN KAZN DNMBP RBM15 MYO18A LCK CEP131 PARD3 TP53 | 4.58e-04 | 512 | 194 | 14 | int:LZTS2 |
| Interaction | CDH1 interactions | ABCF3 MYO7A USP9X SPTBN1 CEMIP2 IQGAP1 FARP2 CGN GOLGB1 UACA PUF60 DVL3 RNF2 NANS PARD3 CCDC65 PCDHGC3 EPB41 | 4.67e-04 | 768 | 194 | 18 | int:CDH1 |
| Interaction | HSP90AA1 interactions | HK2 ACP2 HLA-DRB3 SPTBN1 HLA-DRB5 BMPR1A FBXW8 MYO3B FBXO7 RC3H2 TRPV1 IRS4 EEF1AKMT3 WWP1 DIDO1 LCK GSN MST1R FRK NANS WDR87 PRKG2 STK38L HCK TP53 | 4.87e-04 | 1263 | 194 | 25 | int:HSP90AA1 |
| Interaction | SEPTIN10 interactions | 4.98e-04 | 144 | 194 | 7 | int:SEPTIN10 | |
| Interaction | RHOB interactions | IQGAP2 USP9X SPTBN1 PACSIN3 CEMIP2 IQGAP1 JAG2 BMPR1A UBR2 ABCC1 IRS4 UACA PPP1R9A MYO18A ARHGEF18 OCRL PALS1 MTRF1 PARD3 | 5.01e-04 | 840 | 194 | 19 | int:RHOB |
| Interaction | LATS2 interactions | 5.11e-04 | 289 | 194 | 10 | int:LATS2 | |
| Interaction | CALM3 interactions | ARPP21 SPTBN1 MYO5C IQGAP1 RC3H2 PPP1R9A MYO18A DIDO1 MST1R PALS1 CEP131 | 5.12e-04 | 343 | 194 | 11 | int:CALM3 |
| GeneFamily | PDZ domain containing | RHPN1 PREX1 CARD14 PPP1R9A MYO18A DVL3 PALS1 PALS2 PARD3 PDZRN3 | 1.70e-07 | 152 | 132 | 10 | 1220 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.20e-04 | 66 | 132 | 5 | 722 | |
| GeneFamily | Myosins, class V | 1.58e-04 | 3 | 132 | 2 | 1100 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 8.75e-04 | 26 | 132 | 3 | 904 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.84e-03 | 9 | 132 | 2 | 1230 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 1.58e-05 | 195 | 194 | 9 | M7397 | |
| Coexpression | GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN | 1.71e-05 | 197 | 194 | 9 | M9700 | |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 1.71e-05 | 197 | 194 | 9 | M5480 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN | 1.93e-05 | 200 | 194 | 9 | M7436 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NBEAL1 SPTBN1 IQGAP1 SYNE2 GOLGB1 LCORL WWP1 PPP1R9A FRK ZNF106 R3HDM1 | 8.46e-10 | 191 | 194 | 11 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NBEAL1 SPTBN1 IQGAP1 SYNE2 GOLGB1 LCORL WWP1 PPP1R9A FRK ZNF106 R3HDM1 | 8.46e-10 | 191 | 194 | 11 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NBEAL1 SPTBN1 IQGAP1 SYNE2 LCORL WWP1 PPP1R9A FRK ZNF106 R3HDM1 | 1.26e-08 | 191 | 194 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.40e-07 | 187 | 194 | 9 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-07 | 190 | 194 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 200 | 194 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-06 | 187 | 194 | 8 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-06 | 190 | 194 | 8 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-06 | 191 | 194 | 8 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 191 | 194 | 8 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-06 | 192 | 194 | 8 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-06 | 193 | 194 | 8 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-06 | 193 | 194 | 8 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 2.16e-06 | 193 | 194 | 8 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-06 | 193 | 194 | 8 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.16e-06 | 193 | 194 | 8 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 2.16e-06 | 193 | 194 | 8 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-06 | 198 | 194 | 8 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.81e-06 | 200 | 194 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.81e-06 | 200 | 194 | 8 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 2.81e-06 | 200 | 194 | 8 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.81e-06 | 200 | 194 | 8 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-06 | 200 | 194 | 8 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.81e-06 | 200 | 194 | 8 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.81e-06 | 200 | 194 | 8 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.81e-06 | 200 | 194 | 8 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.81e-06 | 200 | 194 | 8 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-06 | 159 | 194 | 7 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 8.46e-06 | 166 | 194 | 7 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | Immune_cells|World / Lineage and Cell class | 8.46e-06 | 166 | 194 | 7 | f20b58528749ee88fba3ccdaf3f3fa0d06cb9a91 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.80e-06 | 167 | 194 | 7 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-06 | 170 | 194 | 7 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-05 | 171 | 194 | 7 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 173 | 194 | 7 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.11e-05 | 173 | 194 | 7 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 173 | 194 | 7 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.11e-05 | 173 | 194 | 7 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 176 | 194 | 7 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.28e-05 | 177 | 194 | 7 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 178 | 194 | 7 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 178 | 194 | 7 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 179 | 194 | 7 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | ASK452-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.38e-05 | 179 | 194 | 7 | c3cf49c069e66db16d2fce1de4c52a4c4fe7e832 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 179 | 194 | 7 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.38e-05 | 179 | 194 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-05 | 180 | 194 | 7 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 180 | 194 | 7 | 0059e5acade6c895fd629767bea1c15f40b0d1b0 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.43e-05 | 180 | 194 | 7 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 180 | 194 | 7 | dfb8412e1e06fa7349e66eea2ef27d9ea98b7893 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 182 | 194 | 7 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-05 | 183 | 194 | 7 | c9cb69377883d4579c608ec8b265153fe5290e67 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.59e-05 | 183 | 194 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-05 | 185 | 194 | 7 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 187 | 194 | 7 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.89e-05 | 188 | 194 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 188 | 194 | 7 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-05 | 189 | 194 | 7 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 189 | 194 | 7 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 189 | 194 | 7 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 190 | 194 | 7 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 190 | 194 | 7 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-05 | 190 | 194 | 7 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 2.03e-05 | 190 | 194 | 7 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 191 | 194 | 7 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-05 | 191 | 194 | 7 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 192 | 194 | 7 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 192 | 194 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 2.24e-05 | 193 | 194 | 7 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-05 | 193 | 194 | 7 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 2.24e-05 | 193 | 194 | 7 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-05 | 193 | 194 | 7 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.24e-05 | 193 | 194 | 7 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-05 | 193 | 194 | 7 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.24e-05 | 193 | 194 | 7 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 193 | 194 | 7 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 194 | 194 | 7 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 195 | 194 | 7 | b21bf50d689fc3b933182f4bfdde82f375257b72 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 195 | 194 | 7 | b5db3c0e3a41f68fca18e0a74e1b7e81df4f94c5 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.40e-05 | 195 | 194 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 195 | 194 | 7 | 0bdf845939bc4b8cc94f2808aea60f818425b076 | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 2.48e-05 | 196 | 194 | 7 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 196 | 194 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 196 | 194 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.56e-05 | 197 | 194 | 7 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-05 | 197 | 194 | 7 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-05 | 197 | 194 | 7 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.56e-05 | 197 | 194 | 7 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-05 | 197 | 194 | 7 | 8c728cd3c0382c4f3e4b78647b6e1447bb40ace1 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.73e-05 | 199 | 194 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, condition lineage and cell class | 2.73e-05 | 199 | 194 | 7 | a2f154b15087803958a656d2a41b6d83fd37b32f | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-MAIT|Int-URO / Disease, condition lineage and cell class | 2.82e-05 | 200 | 194 | 7 | 043c18e79a969e37bbff86443e553ac09fe33f84 | |
| ToppCell | MS-IIF|MS / Disease, condition lineage and cell class | 2.82e-05 | 200 | 194 | 7 | 221f59edcfc18baece13184c2552d26022228146 | |
| ToppCell | severe_influenza-Treg|World / disease group, cell group and cell class (v2) | 4.90e-05 | 149 | 194 | 6 | 2a3a00cdf604c8f3f3863df0ddb06938549bf86d | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-05 | 150 | 194 | 6 | 1f83e3be3f94aefe991a3ccd292c2d11ddef858e | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-05 | 150 | 194 | 6 | cd666db614bc1b43d71e8eb7bf38cae4d580be80 | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-05 | 150 | 194 | 6 | f6ed3e7b36014d1e429b255b0027d89865e1ac07 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-05 | 153 | 194 | 6 | ad33c81fe6ac10e7c263d42541aae0d796923bad | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-05 | 153 | 194 | 6 | 2a94092937267cd2282452dfde3d328d763d4294 | |
| ToppCell | IIH-CD8-exh_CD4|IIH / Condition, Cell_class and T cell subcluster | 5.88e-05 | 154 | 194 | 6 | a2f51a3c5455fe2483e438375ea856afce8262fe | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.32e-05 | 156 | 194 | 6 | 33deda19f06172079ef1dd49fd54d66da1e7fb14 | |
| Drug | purealin | 3.33e-08 | 58 | 195 | 8 | CID006419303 | |
| Drug | blebbistatin | 7.14e-07 | 116 | 195 | 9 | CID003476986 | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | PDK1 DISC1 NKX3-2 MAPK8IP3 DNAJC28 ZBTB40 ATN1 MUC5B RABEP1 R3HDM1 GRAMD1C | 1.07e-06 | 196 | 195 | 11 | 990_UP |
| Drug | S-(-)-Etomoxir | 2.38e-06 | 100 | 195 | 8 | CID000060765 | |
| Drug | MgCl2 | MYH11 HK2 MYLK MYO1A MYO5A SPTBN1 MYO5C CDH20 MYO3B DNAH9 POLG MYO18A GSN PRM2 | 2.42e-06 | 354 | 195 | 14 | CID000024584 |
| Drug | formycin triphosphate | 4.78e-06 | 51 | 195 | 6 | CID000122274 | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.18e-06 | 191 | 195 | 10 | 3926_DN | |
| Drug | B0683 | 7.71e-06 | 117 | 195 | 8 | CID006398969 | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | DISC1 SPTBN1 NKX3-2 MAPK8IP3 CARD14 ATN1 MUC5B CPE R3HDM1 GRAMD1C | 7.76e-06 | 196 | 195 | 10 | 4423_DN |
| Drug | phosphotyrosine (pY | 1.06e-05 | 203 | 195 | 10 | CID000030819 | |
| Drug | mantATP | 1.15e-05 | 35 | 195 | 5 | CID000123756 | |
| Drug | Zinc Sulfate | MYH11 HK2 IQGAP2 SPTBN1 APC2 HJURP NKX3-2 CRLF3 EEF2K NKX2-2 KAZN MTCL1 CNTF PTGES2 TRPV1 ARHGEF18 LCK TP53 NIN | 2.12e-05 | 739 | 195 | 19 | ctd:D019287 |
| Drug | AC1NPJ0T | 2.27e-05 | 20 | 195 | 4 | CID005159168 | |
| Drug | trifluoperazine | MYH11 MYLK ACACA MYO1A MYO5A SPTBN1 MYO5C MYO3B EEF2K ANXA11 MYO18A PRKG2 | 2.47e-05 | 324 | 195 | 12 | CID000005566 |
| Drug | clenbuterol | 3.16e-05 | 142 | 195 | 8 | CID000002783 | |
| Drug | K-Cl | MYH11 MYLK MYO1A MYO5A MYO5C SAFB MYO3B CGN EEF2K OXSM CARD14 POLG MYO18A CPE GSN SAFB2 | 3.24e-05 | 567 | 195 | 16 | CID000004873 |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 4.33e-05 | 192 | 195 | 9 | 2865_DN | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 4.51e-05 | 193 | 195 | 9 | 462_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; HL60; HT_HG-U133A | 4.88e-05 | 195 | 195 | 9 | 1274_DN | |
| Drug | aminocarb | 5.00e-05 | 9 | 195 | 3 | CID000016247 | |
| Disease | retinal vasculature measurement | MYO5A NBEAL1 SPTBN1 HLA-DRB5 MCM7 FARP2 MYO3B HERC2 DNAH9 TPCN2 MUC12 STRIP1 ZNF106 FRY R3HDM1 TINCR | 2.21e-07 | 517 | 187 | 16 | EFO_0010554 |
| Disease | sarcoidosis | 3.30e-06 | 64 | 187 | 6 | MONDO_0019338 | |
| Disease | mean platelet volume | MYH11 RNLS IQGAP2 MYO5A ACOX1 SPTBN1 TRANK1 CRLF3 EXOC3L4 SYNE2 HTR3D MCF2L HOMEZ PCDHGC5 NARF FRY RABEP1 STK38L PCDHGC3 NIN | 8.29e-06 | 1020 | 187 | 20 | EFO_0004584 |
| Disease | colorectal cancer (implicated_via_orthology) | 3.76e-05 | 30 | 187 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | cutaneous melanoma | 1.26e-04 | 121 | 187 | 6 | EFO_0000389 | |
| Disease | visual masking mesurement | 2.38e-04 | 4 | 187 | 2 | EFO_0803378 | |
| Disease | Megacystis microcolon intestinal hypoperistalsis syndrome | 2.38e-04 | 4 | 187 | 2 | C1608393 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 2.65e-04 | 49 | 187 | 4 | DOID:684 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | MANBA SLC26A4 SPTBN1 DHX38 WDR81 FARP2 TRANK1 EXOC3L4 ZBTB40 UBE2E3 GOLGB1 HOMEZ ADAMTS2 GSN FRK RNF2 STK38L | 2.69e-04 | 1015 | 187 | 17 | EFO_0004533 |
| Disease | non-melanoma skin carcinoma | 3.05e-04 | 265 | 187 | 8 | EFO_0009260 | |
| Disease | megacystis-microcolon-intestinal hypoperistalsis syndrome (is_implicated_in) | 3.95e-04 | 5 | 187 | 2 | DOID:0060610 (is_implicated_in) | |
| Disease | remission, hepatitis C virus infection | 4.04e-04 | 23 | 187 | 3 | EFO_0003047, EFO_0009785 | |
| Disease | Liver carcinoma | KIF18A ACACA EAF2 IQGAP2 ACOX1 HJURP IQGAP1 NDC80 CSPG4 CEP131 TP53 | 4.17e-04 | 507 | 187 | 11 | C2239176 |
| Disease | Congenital muscular dystrophy (disorder) | 5.89e-04 | 6 | 187 | 2 | C0699743 | |
| Disease | Intellectual Disability | DISC1 APC2 LAMA1 MAPK8IP3 ZBTB40 ATN1 PUF60 ZCCHC8 WDR26 FRY | 6.02e-04 | 447 | 187 | 10 | C3714756 |
| Disease | lean body mass | 7.40e-04 | 379 | 187 | 9 | EFO_0004995 | |
| Disease | lymphocyte count | GIMAP4 MANBA ACACA IQGAP2 HLA-DQB2 SLC26A4 HLA-DRB5 IQGAP1 CRLF3 PREX1 ABCC1 GLT6D1 PTGES2 TPCN2 PCDHGC5 LCORL ARHGEF18 MST1R RABEP1 PCDHGC3 | 1.05e-03 | 1464 | 187 | 20 | EFO_0004587 |
| Disease | intestinal cancer (implicated_via_orthology) | 1.09e-03 | 32 | 187 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | hepatitis B virus infection, Susceptibility to viral and mycobacterial infections | 1.09e-03 | 8 | 187 | 2 | EFO_0004197, Orphanet_391311 | |
| Disease | lupus nephritis | 1.19e-03 | 33 | 187 | 3 | EFO_0005761 | |
| Disease | serum alanine aminotransferase measurement | EFCAB11 MANBA HLA-DQB2 DISC1 HLA-DRB3 TRANK1 CDH20 DNMBP PTGES2 TPCN2 LCORL ZCCHC8 FRK NIN | 1.36e-03 | 869 | 187 | 14 | EFO_0004735 |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 1.40e-03 | 9 | 187 | 2 | EFO_0007790 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 1.40e-03 | 9 | 187 | 2 | EFO_0801686 | |
| Disease | primary biliary cirrhosis | 1.62e-03 | 133 | 187 | 5 | EFO_1001486 | |
| Disease | cancer (implicated_via_orthology) | 1.67e-03 | 268 | 187 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | CCL19 measurement | 1.74e-03 | 10 | 187 | 2 | EFO_0009415 | |
| Disease | Abnormality of nervous system morphology | 1.74e-03 | 10 | 187 | 2 | C4022810 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.74e-03 | 10 | 187 | 2 | cv:C4707243 | |
| Disease | body fat distribution | 1.88e-03 | 202 | 187 | 6 | EFO_0004341 | |
| Disease | Brain Neoplasms | 1.94e-03 | 39 | 187 | 3 | C0006118 | |
| Disease | Profound Mental Retardation | 1.96e-03 | 139 | 187 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.96e-03 | 139 | 187 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.96e-03 | 139 | 187 | 5 | C0917816 | |
| Disease | pigmentation disease (is_implicated_in) | 2.12e-03 | 11 | 187 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | lignoceroylcarnitine (C24) measurement | 2.12e-03 | 11 | 187 | 2 | EFO_0800541 | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 2.12e-03 | 11 | 187 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | kidney disease (implicated_via_orthology) | 2.24e-03 | 41 | 187 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | response to antihypertensive drug | 2.24e-03 | 41 | 187 | 3 | EFO_0005405 | |
| Disease | erectile dysfunction | 2.40e-03 | 42 | 187 | 3 | EFO_0004234 | |
| Disease | rac GTPase-activating protein 1 measurement | 2.53e-03 | 12 | 187 | 2 | EFO_0801985 | |
| Disease | B-Cell Lymphomas | 2.53e-03 | 12 | 187 | 2 | C0079731 | |
| Disease | von Willebrand factor measurement, coagulation factor measurement | 2.53e-03 | 12 | 187 | 2 | EFO_0004629, EFO_0004634 | |
| Disease | biliary liver cirrhosis | 2.74e-03 | 44 | 187 | 3 | EFO_0004267 | |
| Disease | carbohydrate measurement | 3.11e-03 | 46 | 187 | 3 | EFO_0004998 | |
| Disease | C-C motif chemokine 19 measurement | 3.46e-03 | 14 | 187 | 2 | EFO_0008047 | |
| Disease | X-21470 measurement | 3.46e-03 | 14 | 187 | 2 | EFO_0800817 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 3.94e-03 | 50 | 187 | 3 | C0023453 | |
| Disease | liver neoplasm | 3.97e-03 | 15 | 187 | 2 | EFO_1001513 | |
| Disease | severe aplastic anemia | 3.97e-03 | 15 | 187 | 2 | EFO_0006927 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 3.97e-03 | 15 | 187 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | C-reactive protein measurement | GIMAP4 CWF19L2 ARPP21 HLA-DQB2 MAPK8IP3 FARP2 TRANK1 PELO ZBTB40 UBR2 LCORL DGKZ HID1 MST1R FRK ZNF106 | 4.41e-03 | 1206 | 187 | 16 | EFO_0004458 |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 4.41e-03 | 52 | 187 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 4.41e-03 | 52 | 187 | 3 | C0023452 | |
| Disease | Cardiovascular Abnormalities | 4.52e-03 | 16 | 187 | 2 | C0243050 | |
| Disease | gastroparesis | 4.52e-03 | 16 | 187 | 2 | EFO_1000948 | |
| Disease | Peripheral Nervous System Diseases | 4.90e-03 | 54 | 187 | 3 | C4721453 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 5.10e-03 | 17 | 187 | 2 | EFO_0010559, GO_0035456 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 5.10e-03 | 17 | 187 | 2 | OBA_2045173 | |
| Disease | Colorectal Carcinoma | ACACA APC2 LAMA1 BMPR1A JAKMIP1 ABCD2 ABCC1 IRS4 CPE LRRC3B TP53 | 5.36e-03 | 702 | 187 | 11 | C0009402 |
| Disease | Amyotrophic Lateral Sclerosis | 5.98e-03 | 58 | 187 | 3 | C0002736 | |
| Disease | fibrinogen measurement, factor VII measurement | 5.98e-03 | 58 | 187 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | skin aging measurement | 6.05e-03 | 181 | 187 | 5 | EFO_0008006 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NIYNIAADRIRHEEA | 371 | Q14146 | |
| QEVHRFVVREYLARA | 571 | Q17RC7 | |
| RERLDGENIYIRHSN | 651 | P11171 | |
| RAELERQRQAYQHDL | 1106 | Q6ZSZ5 | |
| RQRQAYQHDLERLRE | 1111 | Q6ZSZ5 | |
| YQHDLERLREAQRAV | 1116 | Q6ZSZ5 | |
| DRNEEYRRQFTHLPD | 66 | Q8IYS0 | |
| RSRAHLVAVFNEYQR | 386 | P50995 | |
| SRDHLHREQREYLDQ | 1266 | A6NC98 | |
| FHQRDVEQGRVRYLS | 731 | Q6UVK1 | |
| HSRIIANVEEIAFYR | 296 | Q9UBJ2 | |
| IHSRESEDENRYIRN | 281 | Q8IXS2 | |
| SYAERLAAERQHAER | 1016 | P54259 | |
| QQYRQHIQVFIDRFR | 431 | Q9NUQ8 | |
| HIQVFIDRFRYNANR | 436 | Q9NUQ8 | |
| FRKQVNYEVDRRFHR | 1336 | Q13085 | |
| DLEQFERVHRYISDQ | 1076 | Q6XZF7 | |
| QRDEDENVNIYRARH | 206 | Q96AZ1 | |
| LYHNVEGFTDRREAR | 451 | Q92997 | |
| VHHIRRNQIARDDYD | 26 | Q2NKX9 | |
| YNRLRREVEHQETAY | 646 | Q9NRI5 | |
| EEYQRVRERIFAHDS | 286 | Q9UBL0 | |
| RARRHAADDDYNIEV | 256 | O95450 | |
| QREIEIRFDQLHREY | 431 | Q8NCD3 | |
| RDRLQYFRDHINDII | 826 | P46940 | |
| HCRAAYEDFNVQLRR | 106 | Q9HC84 | |
| YNLRRSALEIFHVDQ | 1946 | Q6ZS30 | |
| REEEYQRARDRIFSQ | 286 | Q15032 | |
| RSYEALRREHDAQIV | 271 | Q9HBD1 | |
| RRRVDFHDVQDYADN | 131 | Q969Q5 | |
| RVAYVNFRHPQDARE | 181 | Q8NDT2 | |
| RLRVDFADTEHRYQQ | 521 | Q96T37 | |
| FRNYNTSIDVRRHEL | 726 | Q9UPQ7 | |
| RDQENHYTDRDYRKE | 326 | Q9H0G5 | |
| RDYEHQFHLRLEQER | 126 | Q15276 | |
| ENEQVVFSHRAEIYR | 1351 | Q99666 | |
| ENEQVVFSHRAEIYR | 1351 | O14715 | |
| YFQERNREHERHRDR | 451 | Q8N684 | |
| DERARLRLQQQYASD | 1156 | Q9Y4B5 | |
| VLDRVFERQHYSDIF | 236 | Q02548 | |
| YDFTDTVIRIRNRHN | 136 | Q15118 | |
| EEYEHAVQRRARIYA | 286 | Q9NWU1 | |
| LRDFHRRYNQKNVSE | 256 | Q9H3H1 | |
| DQSIRESRHFQIDYD | 1846 | Q15746 | |
| EAQSRRLEEQRATFY | 71 | Q9Y4H4 | |
| YQVNFSREALQERRA | 586 | Q674X7 | |
| QHRYLFEEDNLLRST | 881 | O00339 | |
| ERVRFLHRDIYNQEE | 51 | Q30154 | |
| QYRQVREHVRNDDGR | 646 | Q9UPT6 | |
| ANVAYQSLRDRDRDQ | 81 | Q9UBC5 | |
| VRLAINYRLHEFDEQ | 4631 | O95714 | |
| NYRLHEFDEQVAAVR | 4636 | O95714 | |
| RRDARNFERYQHNRD | 991 | Q76N89 | |
| VDNRAVRSINEARYA | 1221 | Q9Y219 | |
| SRSHAVFQIYLRQQD | 226 | Q8NI77 | |
| LHRNREDYVERSAEF | 261 | Q8N3X6 | |
| NLRREAFREHQQYKT | 176 | Q96J88 | |
| VTAVAYRLADQHRAR | 456 | P52789 | |
| RHNYEAELRTTLQRQ | 111 | P05538 | |
| RHRGLIRAYEFAVDQ | 551 | Q8N3Y1 | |
| EESRFYEIHARARDQ | 311 | Q9Y5F6 | |
| RLFHERTFVQELERY | 821 | Q92614 | |
| AAFRNYIHRADARQE | 206 | Q96HS1 | |
| QEREAAEYIAQARRQ | 41 | P56589 | |
| HNGLNYREVREFRSD | 71 | Q96HM7 | |
| ERVRYFHDDDNLSLN | 586 | Q2TBE0 | |
| ARENVEAAQSYRREL | 16 | Q8IUI8 | |
| YITRQFVQFDERERH | 246 | Q9H295 | |
| EKHYRQFRADRAAEQ | 151 | Q9NX36 | |
| VSFDRAHIREQYLIQ | 271 | P54098 | |
| REAEAAVYHRQLFEE | 426 | P30613 | |
| AVYHRQLFEELRRAA | 431 | P30613 | |
| EERNYIHRDLRAANI | 356 | P06239 | |
| LEREQEQRRHTAYIS | 56 | Q96N16 | |
| VVYYVRQNQEDARRH | 221 | Q96PB8 | |
| ASQHVFRFYRESLQR | 216 | Q9NQT4 | |
| LRVEYLDDRNTFRHS | 201 | P04637 | |
| REQEERHVREAASYQ | 311 | P14136 | |
| RHVREAASYQEALAR | 316 | P14136 | |
| RNEYFALRVQTREDS | 176 | Q9UN70 | |
| RNQEYLKRFERVQAH | 76 | Q2M2Z5 | |
| QARDEQYRNFLRSVS | 271 | Q13237 | |
| DRDNDLRLAQHITYV | 526 | P33993 | |
| RSRRDQEVAGRDYHF | 516 | Q8N3R9 | |
| HRQEVYVRSTDFDRT | 96 | P11117 | |
| ERRAYFDLQTHVIQV | 221 | Q8WUB8 | |
| AQVFELERRFNHQRY | 216 | P78367 | |
| YLTTRNAEFDRHEIQ | 311 | Q9NZW5 | |
| ESRNYIHRDLAARNV | 346 | P42685 | |
| ERVRYLDRYFHNQEE | 51 | P79483 | |
| FQHEDLNFLTRSQRY | 46 | Q15067 | |
| VATREDYRQVLRDHN | 611 | O95996 | |
| RRRRHAGENDYNIEV | 246 | O15072 | |
| FIEQRNYIHRDLRAA | 371 | P08631 | |
| EARDFQAARYDRHDR | 256 | Q9UJP4 | |
| RDQAYSARDSAQREI | 361 | Q9BXL6 | |
| QYRIPDIDASHNRFR | 221 | Q96CJ1 | |
| RYFRNHQVEELRLSD | 21 | Q7Z4J2 | |
| YLRDFRDNTVRVQDT | 376 | Q9Y3I1 | |
| IHAIQRLDREERAQY | 116 | Q9HBT6 | |
| ERLQENLQAYRTFHV | 71 | P26441 | |
| ERRNVKRHQAYEFQF | 606 | Q5T3F8 | |
| RRRYNRDLEQDEAFI | 186 | P36894 | |
| RRLQQEDGISFEYHR | 41 | P16870 | |
| HEYRNQTFEGRQRER | 2076 | Q9BTC0 | |
| DTHEYRNESRRLQEF | 286 | Q9UHN6 | |
| FYRRSRSEIVDQQGH | 636 | O00462 | |
| FHNRIFLRELENYTD | 691 | O15068 | |
| LAAHIEEYERRNQDY | 481 | P32019 | |
| DDYLNGRAVQHREVQ | 136 | P06396 | |
| AHRYEARQRVDQILE | 141 | Q13683 | |
| DIATERATRHRYNAV | 106 | O00418 | |
| QEFQDRRENLHTYFK | 406 | Q9NYC9 | |
| LDRYSDRNHQITRYQ | 1141 | Q5TBA9 | |
| ETRARVVYRRDQLHF | 121 | Q8IX15 | |
| RYREAARSEIQVLEH | 196 | Q9HAZ1 | |
| DERVQRALHFVISEY | 41 | P09228 | |
| TTASRFYRIDRAQEH | 721 | Q13574 | |
| IYEFHRGFLREVEQR | 586 | O94887 | |
| RYRNEVRHIFTAFDT | 91 | Q9BUY7 | |
| ALSRQLQRQREHYEA | 611 | Q9UPN4 | |
| SRDEYEAHQERVLAR | 116 | Q99496 | |
| ALEHFDRYFLRQSQE | 11 | P0C7X4 | |
| DRYFLRQSQEKREHA | 16 | P0C7X4 | |
| GVSYREVQRIRHEFR | 811 | Q9HB75 | |
| NYRRTVQRVEDGHRL | 21 | Q9UKS6 | |
| RERDYAEIQDFHRTF | 1076 | Q8TEW0 | |
| ENEQVVFSHRAELYR | 1336 | P0DJD0 | |
| IYRAELRVRDINDHS | 116 | Q9Y5E1 | |
| DARYRHLIALFTQDE | 161 | O14654 | |
| HSRSRVFREVETLYQ | 86 | Q9BUB5 | |
| RYREDLDFVLRHINV | 1301 | P33527 | |
| RRQERQRFAEYQAEL | 441 | Q3SY00 | |
| SRYSHVQEVQERLNF | 646 | Q93008 | |
| FYNARRREHRQRNDV | 181 | Q8TAD8 | |
| FYSNLILQHEERETR | 31 | Q9Y2H1 | |
| EARAFNRIYVASVHQ | 221 | Q9UHX1 | |
| RHFTNQREEFEGTRE | 6241 | Q8WXH0 | |
| QEAHYAVRQQRARTE | 286 | Q9NUV9 | |
| DHHAAIERRNEYNLR | 406 | Q8N4C6 | |
| EEYFQEQNSLHDRRD | 146 | Q96GI7 | |
| LSRLQYFRDHNNEIV | 741 | Q13576 | |
| QRNAVDLVYRAEDHA | 1861 | P25391 | |
| NAARQRYEDRIFANT | 331 | Q9Y227 | |
| VNYLSRIHREEDFQF | 326 | Q8IV36 | |
| EVLEHFQAFRSRREE | 766 | Q8TCU6 | |
| ERFNARRYDRAHSNP | 776 | Q5VSL9 | |
| RHLEFSHDQYRELQR | 86 | Q9NR45 | |
| RYHQAFADRDQSERQ | 51 | Q8WW24 | |
| RFRQQRYLSAPEREH | 146 | O95096 | |
| SQHDRALERFYEQVV | 176 | Q9BRX2 | |
| ELFRHQDVATRSRYV | 316 | Q9BRX2 | |
| RHRLQDNVREDLYEA | 296 | Q9H7Z7 | |
| RLQQAEESIRYSRQH | 496 | Q8TF30 | |
| RTYNFTQDRVSDHRI | 386 | O75570 | |
| TQDRVSDHRIAYEVR | 391 | O75570 | |
| QEAAQVAAEYRLVHR | 311 | Q8TCX5 | |
| LAAHVEDFERRNQDY | 376 | Q01968 | |
| ALDERYHSDFNRQDR | 731 | Q15424 | |
| RRLEEAHRAQQYYFD | 1586 | Q01082 | |
| TNQYEQAIFHVAIRR | 211 | Q70Z44 | |
| EHVRQQYQRDTEQLR | 516 | Q9P2M7 | |
| HSRTLAEYIRNNYRE | 571 | Q8IXR9 | |
| AIRQARDERTFHIFY | 271 | P35749 | |
| QEVARDYRDLFHRDF | 271 | Q96JJ7 | |
| RTTNREYFLIGHDRE | 101 | Q5SXH7 | |
| VRSLSERSHEVYRQQ | 6 | P04554 | |
| QQRYHAEEVEERFGR | 271 | Q6NZY4 | |
| LLQETFTADRRHQRY | 466 | Q6ZTK2 | |
| FTADRRHQRYSLETR | 471 | Q6ZTK2 | |
| ETSRLHFRQLRYQEV | 61 | Q53GI3 | |
| HRSRETFQQRRYKCE | 211 | Q6P9A3 | |
| NRRDEDIFRYLTNLQ | 281 | Q9H2G4 | |
| VYSELAFQQQHERRL | 26 | O43511 | |
| RLYDRRSIFEAVAQN | 111 | Q8NER1 | |
| VYFRHRVTQINLRDD | 126 | Q5VYX0 | |
| QYLTNRAEHDRIARQ | 186 | Q969T4 | |
| DSQTHYRLREAQDRA | 156 | Q9Y3Q3 | |
| AYSSEDYVRRREQHL | 341 | Q92620 | |
| RDRGQYQDHAIDRRE | 771 | Q14151 | |
| FYYNARRLDDHQTVR | 56 | A0A2R8Y7D0 | |
| ADADRQHQEVIAIYR | 1371 | Q9BZF9 | |
| LHRYYQNAATDVRRV | 326 | Q96AP4 | |
| HQRIRGYNFEDLTDR | 506 | Q9H7D7 | |
| TFRQRFRRFHYQEVA | 16 | Q8IWY8 | |
| QREVDLEAYFTRNHT | 26 | Q9UJW2 | |
| VDDRRRVYYVDHNTR | 391 | Q9H0M0 | |
| YIHFLFENESARNRR | 2266 | O15050 | |
| RQQRLRLHTSYDVEN | 1191 | Q8IWV8 | |
| EAIVYRHRQALESQD | 2571 | Q6ZQQ6 | |
| VLETSHQNFRRFRYQ | 41 | O95125 | |
| RDILDREYYSVQQHR | 1231 | Q04912 | |
| FVRVYELQSHDRLQV | 1761 | Q9H2Y7 | |
| HRFILLYQARRVEDE | 881 | Q562E7 | |
| VFIEDAIQYRSINHR | 51 | Q8NHX9 | |
| LRRYHENLSEIFTDN | 466 | Q9NUA8 | |
| AERQRRLDYESQTAH | 776 | Q14789 | |
| FSLSQRKRHREQYDV | 5401 | Q9UKN1 | |
| ESQKEFVRRYRQHSE | 146 | Q9UHQ1 | |
| FVRRYRQHSEEERTL | 151 | Q9UHQ1 | |
| ESYRRQFEAIQHCFR | 576 | Q8WXR4 | |
| KSRVVFQAEEERNYH | 246 | Q9Y4I1 | |
| RVVFQSENERNYHIF | 246 | Q9NQX4 | |
| AAAQVFEQRIYAERR | 486 | Q96BF6 | |
| RVCRQALDERNYHVF | 241 | Q13402 | |
| YSVADIERINHERNE | 361 | O14777 | |
| RRQRELLEQHYAQYD | 611 | Q9ULJ8 |